Medicare Enrolled
Dr. Mohammed Qayyum, MD
Cardiovascular Disease · San Jose, CA
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qayyum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qayyum?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qayyum
Dr. Mohammed Qayyum is a cardiovascular disease specialist in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Qayyum performed 7,529 Medicare services across 2,613 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qayyum received a total of $166,291 from 47 pharmaceutical and/or device companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qayyum is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in CA
$166,291 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,529
Medicare services
Top 10% in CA for cardiovascular disease
2,613
Unique beneficiaries
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~396 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
1,920 | $0 | $5 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,392 | $1 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
532 | $42 | $255 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
471 | $160 | $346 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
461 | $78 | $250 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
344 | $23 | $62 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 344 | $406 | $900 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
251 | $189 | $596 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
193 | $113 | $259 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
175 | $71 | $193 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
174 | $39 | $151 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
172 | $1,551 | $3,000 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
157 | $65 | $238 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
147 | $23 | $74 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
147 | $932 | $1,966 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
117 | $23 | $61 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
86 | $25 | $72 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
58 | $52 | $91 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
54 | $27 | $78 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
42 | $14 | $42 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
39 | $11 | $135 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
37 | $19 | $73 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
37 | $16 | $63 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
34 | $81 | $143 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
32 | $4,853 | $15,000 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
32 | $33 | $156 |
| New patient office visit, complex (60-74 min) | 26 | $151 | $486 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
22 | $12 | $80 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
17 | $79 | $200 |
| Cardiac catheterization | 16 | $208 | $2,585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.8% high complexity
40.0% medium
35.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$166,291
Total received (2018-2024)
Avg $23,756/year across 7 years
Top 4% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
500
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$144,423 (86.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,114 (11.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,754 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,695
2023
$3,057
2022
$11,408
2021
$38,096
2020
$39,886
2019
$36,763
2018
$35,384
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$742
Kiniksa Pharmaceuticals International, plc
$202
ShockWave Medical, Inc
$199
PFIZER INC.
$74
Amgen Inc.
$71
Bayer Healthcare Pharmaceuticals Inc.
$54
Novartis Pharmaceuticals Corporation
$50
Baxter Healthcare
$49
Actelion Pharmaceuticals US, Inc.
$47
Kestra Medical Technology Services, Inc.
$34
Esperion Therapeutics, Inc.
$32
Penumbra, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$26
Medtronic, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$22
HEARTFLOW, INC.
$21
AstraZeneca Pharmaceuticals LP
$19
Top 3 companies account for 67.4% of 2024 payments
All-time payments by company (2018-2024) ›
Preventice Services, LLC
$134,000
BOSTON SCIENTIFIC CORPORATION
$9,000
ACIST MEDICAL SYSTEMS, INC.
$4,024
Abbott Laboratories
$3,069
BIOTRONIK INC.
$2,198
Medtronic Vascular, Inc.
$1,709
Cardiovascular Systems Inc.
$1,658
Actelion Pharmaceuticals US, Inc.
$1,467
Edwards Lifesciences Corporation
$871
Amgen Inc.
$844
Janssen Pharmaceuticals, Inc
$728
Acist Medical Systems, Inc.
$636
ShockWave Medical, Inc
$562
Bayer HealthCare Pharmaceuticals Inc.
$425
Terumo Medical Corporation
$424
Regeneron Healthcare Solutions, Inc.
$420
ABIOMED
$398
Shockwave Medical, Inc
$373
Novartis Pharmaceuticals Corporation
$369
AstraZeneca Pharmaceuticals LP
$351
Inari Medical, Inc.
$331
Boston Scientific Corporation
$295
Esperion Therapeutics, Inc.
$258
PFIZER INC.
$234
PORTOLA PHARMACEUTICALS, INC.
$212
Kiniksa Pharmaceuticals International, plc
$202
Bayer Healthcare Pharmaceuticals Inc.
$192
E.R. Squibb & Sons, L.L.C.
$160
Chiesi USA, Inc.
$158
Relypsa, Inc.
$125
Amarin Pharma Inc.
$116
Philips Electronics North America Corporation
$63
Baxter Healthcare
$49
Veryan Medical Incorporated
$42
Merck Sharp & Dohme LLC
$40
Allergan Inc.
$36
Kiniksa Pharmaceuticals, Ltd.
$35
Kestra Medical Technology Services, Inc.
$34
Gilead Sciences, Inc.
$32
Penumbra, Inc.
$29
Medtronic, Inc.
$25
CARDIVA MEDICAL, INC.
$21
HEARTFLOW, INC.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Braemar Manufacturing, LLC
$13
Arrow International, Inc.
$11
InfoBionic, Inc
$11
Top 3 companies account for 88.4% of all-time payments
Associated products mentioned in payments ›
(8333) IGT D Coronary · ANDEXXA · Acticor · Adempas · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BG Mini Plus · BIOMONITOR · BOSENTAN TABLETS · BRILINTA · BYSTOLIC · BioMimics 3D Vascular Stent System · BioMonitor · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CLEVIPREX · CVI SYSTEMS · Cardiac Monitoring Suite · CareLink · Catheter - Specialty Access · Claria MRI · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DRAGONFLY OPSTAR · Devices · Diamondback Coronary · ELIQUIS · ENTRESTO · EVKEEZA · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · Emboshield NAV6 system · Endurant · FARXIGA · FFRct · FLOWTRIEVER CATHETER · Fortify Assura · HD-IVUS · HeartWare HVAD · Hi-Torque Command guide wire · Hillrom - Cardiac Ambulatory Monitor · IGT D Peripheral · IN.PACT Admiral · Impella · JARDIANCE · JOT DX · KENGREAL · Kerendia · LEQVIO · Letairis · MICRA · Merlin Connectivity and Remote · MetaCross · Micra · MoMe Kardia · NEXLETOL · Navicross · Nuclear · OPSUMIT · OPSUMIT MACITENTAN · OPTIS · Optitorque · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · RXI SYSTEMS · Repatha · Resolute · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · TR Band · ULTREON · UPTRAVI · VERQUVO · Vascepa · Vascular Lithotripsy · Veltassa · WATCHMAN · WATCHMAN FLX · XARELTO · XIENCE SKYPOINT · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
205
Per 100K population
10.8
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qayyum is a remote & cardiac specialist, with above-average Medicare volume (top 10% in CA), with consulting-driven industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qayyum experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Qayyum performed 1,920 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qayyum receive payments from pharmaceutical companies?
Yes. Dr. Qayyum received a total of $166,291 from 47 companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qayyum's costs compare to other cardiologists in San Jose?
Dr. Qayyum's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qayyum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Jose
Browse cardiologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Preventice Services, LLC Payments to Doctors
See all physicians who received payments from Preventice Services, LLC.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
ACIST MEDICAL SYSTEMS, INC. Payments to Doctors
See all physicians who received payments from ACIST MEDICAL SYSTEMS, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology